364 related articles for article (PubMed ID: 33009284)
41. Determinants of severity among hospitalised COVID-19 patients: Hospital-based case-control study, India, 2020.
Zodpey SP; Negandhi H; Kamal VK; Bhatnagar T; Ganeshkumar P; Athavale A; Kadri A; Patel A; Bhagyalaxmi A; Khismatrao D; Theranirajan E; Banumathi G; Singh K; Parameshwari P; Kshirsagar P; Saxena R; Deshpande SG; Satyanand K; Hadke S; Dube S; Subramaniam S; Madan S; Kadam S; Anand T; Jeyashree K; Ponnaiah M; Rana M; Murhekar MV; Reddy D
PLoS One; 2021; 16(12):e0261529. PubMed ID: 34965276
[TBL] [Abstract][Full Text] [Related]
42. Prognosis of COVID-19: Changes in laboratory parameters.
Lagadinou M; Salomou EE; Zareifopoulos N; Marangos M; Gogos C; Velissaris D
Infez Med; 2020 Jun; 28(suppl 1):89-95. PubMed ID: 32532944
[TBL] [Abstract][Full Text] [Related]
43. Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection : A Retrospective Cohort Study.
Anderson MR; Geleris J; Anderson DR; Zucker J; Nobel YR; Freedberg D; Small-Saunders J; Rajagopalan KN; Greendyk R; Chae SR; Natarajan K; Roh D; Edwin E; Gallagher D; Podolanczuk A; Barr RG; Ferrante AW; Baldwin MR
Ann Intern Med; 2020 Nov; 173(10):782-790. PubMed ID: 32726151
[TBL] [Abstract][Full Text] [Related]
44. Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab.
Morrison AR; Johnson JM; Griebe KM; Jones MC; Stine JJ; Hencken LN; To L; Bianchini ML; Vahia AT; Swiderek J; Ramesh MS; Peters MA; Smith ZR
J Autoimmun; 2020 Nov; 114():102512. PubMed ID: 32646770
[TBL] [Abstract][Full Text] [Related]
45. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
[TBL] [Abstract][Full Text] [Related]
46. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe.
Valverde I; Singh Y; Sanchez-de-Toledo J; Theocharis P; Chikermane A; Di Filippo S; Kuciñska B; Mannarino S; Tamariz-Martel A; Gutierrez-Larraya F; Soda G; Vandekerckhove K; Gonzalez-Barlatay F; McMahon CJ; Marcora S; Napoleone CP; Duong P; Tuo G; Deri A; Nepali G; Ilina M; Ciliberti P; Miller O;
Circulation; 2021 Jan; 143(1):21-32. PubMed ID: 33166189
[TBL] [Abstract][Full Text] [Related]
47. Laboratory biomarkers associated with COVID-19 severity and management.
Keddie S; Ziff O; Chou MKL; Taylor RL; Heslegrave A; Garr E; Lakdawala N; Church A; Ludwig D; Manson J; Scully M; Nastouli E; Chapman MD; Hart M; Lunn MP
Clin Immunol; 2020 Dec; 221():108614. PubMed ID: 33153974
[TBL] [Abstract][Full Text] [Related]
48. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
49. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.
Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM
PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801
[TBL] [Abstract][Full Text] [Related]
50. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis.
Malik P; Patel U; Patel NH; Somi S; Singh J
Infez Med; 2020 Dec; 28(4):500-506. PubMed ID: 33257623
[TBL] [Abstract][Full Text] [Related]
51. Biomarker-guided application of low-dose anakinra in an acute respiratory distress syndrome patient with severe COVID-19 and cytokine release syndrome.
Steinhardt MJ; Wiebecke S; Weismann D; Frantz S; Tony HP; Klinker H; Schmalzing M
Scand J Rheumatol; 2020 Sep; 49(5):414-416. PubMed ID: 32914670
[No Abstract] [Full Text] [Related]
52. Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019.
Latif F; Farr MA; Clerkin KJ; Habal MV; Takeda K; Naka Y; Restaino S; Sayer G; Uriel N
JAMA Cardiol; 2020 Oct; 5(10):1165-1169. PubMed ID: 32402056
[TBL] [Abstract][Full Text] [Related]
53. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
Agbuduwe C; Basu S
Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
[TBL] [Abstract][Full Text] [Related]
54. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection.
Lopez-Castaneda S; García-Larragoiti N; Cano-Mendez A; Blancas-Ayala K; Damian-Vázquez G; Perez-Medina AI; Chora-Hernández LD; Arean-Martínez C; Viveros-Sandoval ME
Clin Appl Thromb Hemost; 2021; 27():1076029621999099. PubMed ID: 33835872
[TBL] [Abstract][Full Text] [Related]
55. Cardiovascular biomarkers in COVID-19.
Omland T; Mills NL; Mueller C;
Eur Heart J Acute Cardiovasc Care; 2021 Jun; 10(5):473-474. PubMed ID: 34125174
[No Abstract] [Full Text] [Related]
56. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
[TBL] [Abstract][Full Text] [Related]
57. Established Cardiovascular Biomarkers Provide Limited Prognostic Information in Unselected Patients Hospitalized With COVID-19.
Omland T; Prebensen C; Røysland R; Søvik S; Sørensen V; Røsjø H; Svensson M; Berdal JE; Myhre PL
Circulation; 2020 Nov; 142(19):1878-1880. PubMed ID: 32910681
[No Abstract] [Full Text] [Related]
58. Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.
Santa Cruz A; Mendes-Frias A; Oliveira AI; Dias L; Matos AR; Carvalho A; Capela C; Pedrosa J; Castro AG; Silvestre R
Front Immunol; 2021; 12():613422. PubMed ID: 33679753
[TBL] [Abstract][Full Text] [Related]
59. Potential Mechanisms of Cardiac Injury and Common Pathways of Inflammation in Patients With COVID-19.
Centurión OA; Scavenius KE; García LB; Torales JM; Miño LM
Crit Pathw Cardiol; 2021 Mar; 20(1):44-52. PubMed ID: 32467423
[TBL] [Abstract][Full Text] [Related]
60. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
